A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. [electronic resource]
Producer: 20140121Description: 968-75 p. digitalISSN:- 1740-634X
- Adolescent
- Adult
- Antipsychotic Agents -- therapeutic use
- Benzofurans -- therapeutic use
- Female
- Humans
- India -- epidemiology
- Male
- Middle Aged
- Nicotinic Agonists -- therapeutic use
- Nootropic Agents -- therapeutic use
- Quinuclidines -- therapeutic use
- Schizophrenia -- drug therapy
- Schizophrenic Psychology
- United States -- epidemiology
- Young Adult
- alpha7 Nicotinic Acetylcholine Receptor -- physiology
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.